Eledon Pharmaceuticals Inc (ELDN)
R&D Expense Growth
6.01%
Quarterly · Period ending:
ELDN R&D Expense Growth
Latest reported6.01%period ending
Latest reported6.01%period ending
ELDN Quarterly R&D Growth (QoQ) (0.00% → 6.01%)
Latest values, visible window
High-resolution chart · PNG
ELDN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 6.0069% | |
| -1.6809% | |
| 16.8482% | |
| -26.1738% | |
| 49.8485% | |
| -24.5259% | |
| 8.523% | |
| 63.4672% | |
| 36.3833% | |
| 4.8535% | |
| -10.894% | |
| 10.1375% | |
| -11.2412% | |
| 11.9034% | |
| -2.7107% | |
| 29.758% | |
| -13.4439% | |
| 7.3277% | |
| -19.274% | |
| 80.5281% | |
| -24.9602% | |
| 86.1989% | |
| 393.6585% | |
| -26.0817% | |
| -49.5146% | |
| 23.6309% | |
| -11.6634% | |
| -34.3056% | |
| -23.1516% | |
| 9.0876% | |
| 65.96% | |
| 24.2287% | |
| 21.1486% | |
| 122.5152% | |
| -4.6422% | |
| -3.0019% | |
| 74.183% | |
| -70.4633% | |
| -83.1873% | |
| -37.7261% | |
| 24.7636% | |
| 2.5605% | |
| -8.9271% | |
| 45.0213% | |
| -44.5497% | |
| 177.5762% | |
| 34.6549% | |
| -35.6785% | |
| 23.5096% | |
| -18.2341% | |
| 60.8358% | |
| 0% |